Literature DB >> 33206331

The diagnostic value of miR-21 combined with CT in patients with liver cancer.

Y S Feng1, J M Zhou2, C H Sun3, J Zhu4, J Yang5, L Guo6.   

Abstract

PURPOSE: To explore the diagnostic value of miR-21 combined with computed tomography (CT) in patients with liver cancer.
METHODS: A total of 112 patients in our hospital were confirmed liver cancer by examination, and were collected as cancer group. Another 100 patients with hepatic focal nodular hyperplasia in the same period were collected as control group. The diagnostic value of miR-21 and CT on liver cancer was observed.
RESULTS: The level of miR-21 in cancer group was significantly higher than that in control group, the difference was statistically significant (p < 0.05). The alpha-fetoprotein (AFP) level was tested. It was found that the AFP level in cancer group was significantly higher than that in control group (p < 0.001). The correlation between AFP and miR-21 levels in liver cancer patients was detected. It turned out that AFP and miR-21 had correlation. According to receiver operating curve (ROC) calculation results, the best cut-off value for miR-21 diagnosis was 4.142. The sensitivity, specificity and accuracy of diagnosis of miR-21 alone were 64.29%, 87.00% and 75.00%, respectively. The sensitivity, specificity and accuracy of diagnosis of CT alone were 91.07%, 62.00% and 77.36%, respectively. There were 108 cases of true positive and 80 cases of true negative after combined diagnosis in the two groups. The sensitivity, specificity and accuracy of combined diagnosis were 96.43%, 80.00% and 88.68%, respectively. Comparing the value of single diagnosis and combined diagnosis, we found that the accuracy, sensitivity and specificity of combined diagnosis were significantly higher than that of single diagnosis (p < 0.05).
CONCLUSION: CT combined with miR-21 has great diagnostic value in liver cancer and may be a potential diagnostic indicator for liver cancer.

Entities:  

Keywords:  CT; Diagnosis; Liver cancer; miR-21

Mesh:

Substances:

Year:  2020        PMID: 33206331     DOI: 10.1007/s12094-020-02514-4

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  6 in total

1.  Programmed cell death-1 in patients with primary liver cancer and its effect on prognosis.

Authors:  Min Yang; Wen Wen Dou; Guang Hong Sun; Yan Lan Zhang; Yan Su; Rui Zhu Xie
Journal:  J BUON       Date:  2019 May-Jun       Impact factor: 2.533

2.  Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis.

Authors:  Ke-Cheng Zhang; Hong-Qing Xi; Jian-Xin Cui; Wei-Song Shen; Ji-Yang Li; Bo Wei; Lin Chen
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

3.  Clinical value of spectral CT imaging combined with AFP in identifying liver cancer and hepatic focal nodular hyperplasia.

Authors:  Rui Xu; Jing Wang; Xiaoyu Huang; Qiaoying Zhang; Yijing Xie; Lan Pang; Liangcai Bai; Junlin Zhou
Journal:  J BUON       Date:  2019 Jul-Aug       Impact factor: 2.533

4.  CT combined with tumor markers in the diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Xingwen Huang; Jianlin Li; Fuzheng Wang; Mingda Hao
Journal:  J BUON       Date:  2018 Jul-Aug       Impact factor: 2.533

5.  Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients.

Authors:  Yoshinaga Okugawa; Li Yao; Yuji Toiyama; Akira Yamamoto; Tsunehiko Shigemori; Chengzeng Yin; Yusuke Omura; Shozo Ide; Takahito Kitajima; Tadanobu Shimura; Hiroyuki Fujikawa; Hiromi Yasuda; Junichiro Hiro; Shigeyuki Yoshiyama; Minako Kobayashi; Koji Tanaka; Yasuhiro Inoue; Toshimitsu Araki; Chikao Miki; Masato Kusunoki
Journal:  Oncol Rep       Date:  2018-02-14       Impact factor: 3.906

6.  Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma.

Authors:  Hongwei Wang; Lijuan Hou; Aihui Li; Yuxiu Duan; Haili Gao; Xinwen Song
Journal:  Biomed Res Int       Date:  2014-05-18       Impact factor: 3.411

  6 in total
  2 in total

Review 1.  Chemokine signaling in cancer-stroma communications.

Authors:  Arun J Singh; Joe W Gray
Journal:  J Cell Commun Signal       Date:  2021-06-04       Impact factor: 5.782

2.  HBV Promotes the Proliferation of Liver Cancer Cells through the hsa_circ_0000847/miR-135a Pathway.

Authors:  Jianjun Lin; Xiang Lian; Shihang Xue; Lian Ouyang; Lihui Zhou; Yuyang Lu; Longteng Xie
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-15       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.